ISCO

International Stem Cell (QB) (ISCO)

International Stem Cell Corporation (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ISCO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/11/14	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/11/09	03 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/11/09	03 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/09/28	01 : 27	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/09/18	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/08/12	03 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/06/22	03 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/06/17	06 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/05/13	05 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/04/29	05 : 31	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/03/31	05 : 37	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2023/03/17	03 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/11/15	06 : 05	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/08/13	04 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/06/14	19 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/06/11	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/06/11	06 : 02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/05/14	00 : 55	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/04/29	20 : 52	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/04/28	05 : 32	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/04/27	07 : 39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/03/30	05 : 38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2022/03/04	06 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2021/11/13	06 : 02	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
2021/11/02	05 : 44	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2021/08/14	05 : 03	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:ISCO	International Stem Cell Corporation (QB)
2021/07/01	05 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2021/06/15	05 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:ISCO	International Stem Cell Corporation (QB)
2021/06/12	03 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)
2021/06/12	03 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:ISCO	International Stem Cell Corporation (QB)